Literature DB >> 10443738

Ventriculoperitoneal shunt infection after bladder augmentation.

K Pinto1, G R Jerkins, H N Noe.   

Abstract

OBJECTIVES: To examine the incidence of postoperative ventriculoperitoneal shunt infections in patients after augmentation cystoplasty.
METHODS: We retrospectively reviewed the charts of 21 patients with a ventriculoperitoneal shunt who had bladder augmentation (18 ileal and 3 ileocecal) with attention to the preoperative urine culture, perioperative antibiotics, and the length of time drains were maintained. The abdominal end of all shunts was wrapped in an antibiotic-soaked sponge during the procedure. All patients had at least 1 year of follow-up.
RESULTS: Seven patients (33%) had culture proven, preoperative urinary tract infections. All patients received at least 24 hours of preoperative and 48 hours of postoperative antibiotics. No postoperative shunt infections occurred during the study period.
CONCLUSIONS: The incidence of postoperative ventriculoperitoneal shunt infections after augmentation cystoplasty can be kept low when prophylactic antibiotics and short-term drains are used.

Entities:  

Mesh:

Year:  1999        PMID: 10443738     DOI: 10.1016/s0090-4295(99)00157-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

Review 1.  Ventriculorenal shunts in the treatment of pediatric and adult hydrocephalus-historical perspective and analysis of current practice.

Authors:  Cezar Octavian Morosanu; Adelina Priscu; Razvan George Rahota; Ioan Stefan Florian
Journal:  Childs Nerv Syst       Date:  2022-10-20       Impact factor: 1.532

2.  Gastrointestinal cancer surgery in patients with a prior ventriculoperitoneal shunt: the department of veterans affairs experience.

Authors:  Shilpi Wadhwa; George K Hanna; Andrew R Barina; Riccardo A Audisio; Katherine S Virgo; Frank E Johnson
Journal:  Gastrointest Cancer Res       Date:  2012-07

3.  Urinary perforation in spina bifida: Neurosurgical and infectious consequences.

Authors:  Deborah Callanan; Timothy Phillips; Micam Tullous
Journal:  SAGE Open Med Case Rep       Date:  2017-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.